Literature DB >> 10859579

Community impact of anticoagulation services: rationale and design of the Managing Anticoagulation Services Trial (MAST).

D B Matchar1, G P Samsa, S J Cohen, E Z Oddone.   

Abstract

We describe the design of the Managing Anti-coagulation Services Trial (MAST), a practice-improvement trial testing whether anticoagulation services are a preferred method of managing anticoagulation for stroke prevention among patients with atrial fibrillation. Most randomized trials within the health care environment are designed as efficacy studies to determine what works under ideal conditions or ideal clinical practice. In contrast, effectiveness trials seek to generalize the results of efficacy studies by determining what works under more typical practice conditions. Practice-improvement trials are effectiveness trials that examine the management of a clinical problem in the context in which care is usually given. Noteworthy features of the MAST include defining the intervention in functional terms and collaboration with managed care organizations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859579     DOI: 10.1023/a:1018722001817

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  16 in total

Review 1.  Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.

Authors:  J Hirsh; J E Dalen; D Deykin; L Poller
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

2.  Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

Authors:  D B Matchar; G P Samsa; S J Cohen
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

3.  Anticoagulation therapy: patient management and evaluation of an outpatient clinic.

Authors:  P Kornblit; J Senderoff; M Davis-Ericksen; J Zenk
Journal:  Nurse Pract       Date:  1990-08

Review 4.  Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.

Authors:  J Hirsh; J E Dalen; D Deykin; L Poller; H Bussey
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

5.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

6.  Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy.

Authors:  R F Ellis; M A Stephens; G B Sharp
Journal:  Am J Hosp Pharm       Date:  1992-02

7.  National patterns of warfarin use in atrial fibrillation.

Authors:  R S Stafford; D E Singer
Journal:  Arch Intern Med       Date:  1996 Dec 9-23

8.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

Authors:  F J van der Meer; F R Rosendaal; J P Vandenbroucke; E Briët
Journal:  Arch Intern Med       Date:  1993-07-12

9.  Medical treatment for stroke prevention.

Authors:  D B Matchar; D C McCrory; H J Barnett; J R Feussner
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  6 in total

Review 1.  Tailored interventions to address determinants of practice.

Authors:  Richard Baker; Janette Camosso-Stefinovic; Clare Gillies; Elizabeth J Shaw; Francine Cheater; Signe Flottorp; Noelle Robertson; Michel Wensing; Michelle Fiander; Martin P Eccles; Maciek Godycki-Cwirko; Jan van Lieshout; Cornelia Jäger
Journal:  Cochrane Database Syst Rev       Date:  2015-04-29

2.  An evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481--The Home INR Study (THINRS).

Authors:  Rowena J Dolor; R Lynne Ruybalid; Lauren Uyeda; Robert G Edson; Ciaran Phibbs; Julia E Vertrees; Mei-Chiung Shih; Alan K Jacobson; David B Matchar
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

3.  At-Home Versus In-Clinic INR Monitoring: A Cost-Utility Analysis from The Home INR Study (THINRS).

Authors:  Ciaran S Phibbs; Sean R Love; Alan K Jacobson; Robert Edson; Pon Su; Lauren Uyeda; David B Matchar
Journal:  J Gen Intern Med       Date:  2016-05-27       Impact factor: 5.128

Review 4.  Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes.

Authors:  Richard Baker; Janette Camosso-Stefinovic; Clare Gillies; Elizabeth J Shaw; Francine Cheater; Signe Flottorp; Noelle Robertson
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

5.  The impact of frequency of patient self-testing of prothrombin time on time in target range within VA Cooperative Study #481: The Home INR Study (THINRS), a randomized, controlled trial.

Authors:  David B Matchar; Sean R Love; Alan K Jacobson; Robert Edson; Lauren Uyeda; Ciaran S Phibbs; Rowena J Dolor
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

6.  Attitudes and preferences on the use of mobile health technology and health games for self-management: interviews with older adults on anticoagulation therapy.

Authors:  Jung-Ah Lee; Annie Lu Nguyen; Jill Berg; Alpesh Amin; Mark Bachman; Yuqing Guo; Lorraine Evangelista
Journal:  JMIR Mhealth Uhealth       Date:  2014-07-23       Impact factor: 4.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.